Atai Beckley Inc.

NASDAQ:ATAI

Biotechnology

Healthcare
$7.35 -1.35%

-$0.06 today

Market cap
$2.72B
Beta
1.60
P/E (TTM)
-1.4
EPS (TTM)
-$2.93
52W Low $2.00High $6.75

Volume 0.00M

Average 5.68M

ATAI Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

Atai Beckley Inc.NASDAQ: ATAI

Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026

Other current liabilities falls 5.7% from a year ago

Other current liabilities stood at $771K at the end of Q2 FY2026, down 5.7% from a year earlier and down 71.7% from the prior quarter. Over 3 fiscal years it compounded at +149.2% a year.

Context

  • Other current liabilities amounted to 0.3% of total assets at the end of Q2 FY2026, down 0.1 pp from a year earlier.
  • Other current liabilities increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other current liabilities keeps falling in the next quarterly balance sheet after a -5.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$771K-71.7% QoQ
Last fiscal yearDec 2025
$11.11M+319.6% YoY
Year agoJun 2025
$818K-5.7% since
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.7%——
1 year+319.6%——
3-year CAGR+149.2%——
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
11.11M USD
Year-over-year change
+319.6%
4-year CAGR
+154.4%

Other Current Liabilities vs competitors

How ATAI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -5.7% is the 8th highest of 11, against a peer median of +76.5%.
  • Other current liabilities amounts to 0.3% of total assets for ATAI, versus a peer median of 1.2%.
ATAI Competitors
Other Current Liabilities for ATAI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SANASana Biotechnology, Inc.Mar 2026$58.94M USD+802.4%-12.2%15.8%
ELVNEnliven Therapeutics, Inc.Sep 2026$19.47M USD+382.0%+144.0%2.2%
SNDXSyndax Pharmaceuticals, Inc.Mar 2026$18.2M USD-30.4%+150.6%3.9%
NKTRNektar TherapeuticsJun 2026$16.36M USD+149.7%+32.5%1.5%
INBXInhibrx Biosciences, Inc.Mar 2026$15.34M USD+464.5%+9.3%8.3%
DNTHDianthus Therapeutics, Inc.Jun 2026$5.61M USD+47.5%+65.9%0.5%
IMTXImmatics N.V.Mar 2026€5.24M EUR-20.0%-46.0%1.0%
ORICORIC Pharmaceuticals, Inc.Mar 2026$3.8M USD-5.1%+29.6%0.9%
RLAYRelay Therapeutics, Inc.Jun 2026$1.25M USD+105.6%-73.9%0.1%
ATAIAtai Beckley Inc.Jun 2026$771K USD-5.7%+149.2%0.3%
AMLXAmylyx Pharmaceuticals, Inc.Sep 2026$0 USD-100.0%-12.9%0.0%
Peer median (excluding ATAI) —+76.5%+19.5%1.2%

Competitors are the stored peer set for ATAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents362.27M190.61M45.03M17.51M85.3M
Short-term Investments082.5M134.22M44.83M170.74M
Net Receivables6.32M5.63M2.26M1.35M14.43M
Inventory00000
Other Current Assets756K1.75M846K10.78M946K
Total Current Assets375.08M287.15M185.59M80.13M275.68M
Property, Plant & Equipment (Net)149K1.15M2.2M3.87M4.01M
Goodwill000331K331K
Intangible Assets001.77M3.25M11.59M
Long-term Investments27.76M6.76M91.66M70.97M900K
Tax Assets000017.82M
Other Non-current Assets11.18M10.39M12.25M850K210K
Total Non-current Assets39.08M18.3M107.89M79.26M34.86M
Total Assets414.17M305.44M293.48M159.39M310.54M
Account Payables6M2.4M4.59M2.62M4.91M
Short-term Debt0009.36M271K
Tax Payables8.14M2.22M715K188K0
Deferred Revenue00001.52M
Other Current Liabilities265K718K1.1M2.65M11.11M
Total Current Liabilities20.94M19.9M20.12M24.95M23.48M
Long-term Debt743K15.12M17.88M14.13M0
Deferred Tax Liabilities000017.82M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities6.53M4.62M10.18M3.02M45.44M
Total Non-current Liabilities7.27M19.78M29.04M17.88M65.06M
Total Liabilities28.21M39.68M49.16M42.83M88.54M
Common Stock18M18.56M18.57M18.79M3.63M
Retained Earnings(357.8M)(510.19M)(550.94M)(700.21M)(1.36B)
Accumulated OCI(8.34M)(21.7M)(19.46M)(18.47M)(20.93M)
Other Stockholders Equity0(24K)000
Minority Interest9.05M5.03M1.35M257K127K
Total Equity385.96M265.77M244.32M116.55M222M
Total Debt743K15.34M19.14M24.71M2.07M
Net Debt(361.52M)(175.27M)(25.89M)7.2M(83.23M)

Atai Beckley Inc.

NASDAQ:ATAI

Intrinsic Alpha fair value

Locked

Current Price

$7.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.